RSC
LLY icon

Red Spruce Capital’s Eli Lilly LLY Stock Holding History

Red Spruce Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.68M Sell
4,044
-41
-1% -$48.4K 1.65% 17
2026
Q2 		$4.9M Sell
4,085
-145
-3% -$148K 1.71% 17
2026
Q1 		$3.89M Sell
4,230
-9
-0.2% -$9.12K 1.6% 18
2025
Q4 		$4.56M Sell
4,239
-60
-1% -$57.4K 1.82% 14
2025
Q3 		$3.28M Buy
4,299
+2,073
+93% +$1.54M 1.34% 27
2025
Q2 		$1.74M Hold
2,226
– – 0.75% 50
2025
Q1 		$1.84M Sell
2,226
-28
-1% -$23.3K 0.86% 44
2024
Q4 		$1.74M Sell
2,254
-33
-1% -$27.3K 0.77% 49
2024
Q3 		$2.03M Sell
2,287
-78
-3% -$70.1K 0.92% 41
2024
Q2 		$2.14M Sell
2,365
-26
-1% -$20.8K 0.99% 35
2024
Q1 		$1.86M Sell
2,391
-703
-23% -$500K 0.86% 44
2023
Q4 		$1.8M Sell
3,094
-100
-3% -$58.4K 0.93% 41
2023
Q3 		$1.72M Sell
3,194
-240
-7% -$124K 0.97% 38
2023
Q2 		$1.61M Sell
3,434
-33
-1% -$13.8K 0.87% 45
2023
Q1 		$1.19M Sell
3,467
-117
-3% -$39.5K 0.7% 52
2022
Q4 		$1.31M Buy
3,584
+4
+0.1% +$1.42K 0.83% 44
2022
Q3 		$1.16M Sell
3,580
-48
-1% -$15.2K 0.81% 46
2022
Q2 		$1.18M Hold
3,628
– – 0.78% 49
2022
Q1 		$1.04M Sell
3,628
-4,877
-57% -$1.26M 0.59% 56
2021
Q4 		$2.35M Sell
8,505
-4,810
-36% -$1.22M 1.29% 26
2021
Q3 		$3.08M Buy
13,315
+146
+1% +$36K 1.8% 13
2021
Q2 		$3.02M Sell
13,169
-446
-3% -$89.6K 1.78% 13
2021
Q1 		$2.54M Buy
13,615
+243
+2% +$47.5K 1.62% 17
2020
Q4 		$2.26M Sell
13,372
-35
-0.3% -$5.23K 1.57% 19
2020
Q3 		$1.98M Sell
13,407
-66
-0.5% -$10.2K 1.61% 20
2020
Q2 		$2.21M Sell
13,473
-7
-0.1% -$1.07K 1.88% 15
2020
Q1 		$1.87M Sell
13,480
-225
-2% -$30.9K 1.94% 12
2019
Q4 		$1.8M Buy
+13,705
New +$1.59M 1.5% 23

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Red Spruce Capital's LLY Position: Q3 2026 in Review

Red Spruce Capital reduced its Eli Lilly (LLY) stake by 1% in Q3 2026, selling an estimated $48.4K and leaving 4,044 shares worth $4.68M. The position accounts for 1.65% of the portfolio, ranked #17.

Red Spruce Capital first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $4.9M in Q2 2026. 960 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Red Spruce Capital held 4,044 shares of Eli Lilly worth $4.68M as of Q3 2026.
  • Red Spruce Capital sold 41 Eli Lilly shares in Q3 2026, an estimated $48.4K.
  • Eli Lilly made up 1.65% of Red Spruce Capital's portfolio in Q3 2026, its #17 holding.
  • Red Spruce Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • Red Spruce Capital's Eli Lilly position peaked at $4.9M in Q2 2026.
  • 960 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Red Spruce Capital's 13F filing for Q3 2026, filed 7 Oct 2026.